This site is intended for healthcare professionals
Bone marrow aspirate cytology of multiple myeloma, a type of bone marrow cancer of malignant plasma cells.

Transcript: Unmet needs in MM

Sponsored by Menarini Stemline
Last updated: 19th Feb 2025
Published: 19th Feb 2025

Enrique Ocio, MD, PhD

All transcripts are created from interview footage and directly reflect the content of the interview at the time. The content is that of the speakers and is not adjusted by Medthority.

So therapies.
Mi GPRC5D.
Mein Umleitungstherapien.
Mon GPRC5.

View video

Welcome:

This content has been developed in partnership with Menarini Stemline. This content has been sponsored by Menarini Stemline. The content hosted on this platform is intended for educational purposes. Any data about non-Menarini Stemline products are based on publicly available information. Prescribing information may vary depending on local health authority approval in each country. Before prescribing any product, always refer to the Summary of Product Characteristics (SmPC) or product information approved in your local country. This educational activity is intended for healthcare professionals only.

Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit–risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system. Adverse events should also be reported to Menarini Stemline. Please refer to the Summary of Product Characteristics (SmPC) or product information approved in your local country for further information.

MED-GL-2500132, December 2025